Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ketamine for Acute Traumatic Extremity Pain
NCT04162028Phase 4Withdrawn
- Start
- Jan 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine. Planned start Jan 2019; status: withdrawn.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT04162028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04162028.